Nabriva Therapeutics PLC (NBRV)
1.496
+0.04
(+2.46%)
USD |
NASDAQ |
Jun 05, 16:00
1.43
-0.07
(-4.41%)
After-Hours: 20:00
Nabriva Therapeutics Profit Margin (Quarterly): -114.6% for March 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | -114.6% |
| December 31, 2022 | -218.2% |
| September 30, 2022 | -131.1% |
| June 30, 2022 | -126.2% |
| March 31, 2022 | -154.1% |
| December 31, 2021 | -146.6% |
| September 30, 2021 | -126.5% |
| June 30, 2021 | -151.6% |
| March 31, 2021 | -655.8% |
| December 31, 2020 | -876.3% |
| September 30, 2020 | -2.28K% |
| Date | Value |
|---|---|
| June 30, 2020 | |
| March 31, 2020 | -7.73K% |
| December 31, 2019 | -9.14K% |
| September 30, 2019 | -273.9% |
| June 30, 2019 | |
| March 31, 2019 | -2.02K% |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | -205.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-9.14K%
Minimum
Dec 2019
-114.6%
Maximum
Mar 2023
-1.61K%
Average
-218.2%
Median
Dec 2022
Profit Margin (Quarterly) Benchmarks
| Avadel Pharmaceuticals PLC | -- |
| Medtronic PLC | 13.80% |
| Jazz Pharmaceuticals PLC | 7.78% |
| Iterum Therapeutics PLC | -- |
| Mallinckrodt PLC | -58.71% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -260.5% |
| Return on Assets | -120.1% |
| Return on Invested Capital | -206.5% |
| Gross Profit Margin (Quarterly) | 41.53% |
| Operating Margin (Quarterly) | -111.7% |
| Return on Net Operating Assets | -178.6% |